Selected article for: "acute heart and logistic regression"
Author: Suárez-García, Inés; Perales-Fraile, Isabel; González-García, Andrés; Muñoz-Blanco, Arturo; Manzano, Luis; Fabregate, Martín; Díez-Manglano, Jesús; Aizpuru, Eva Fonseca; Fernández, Francisco Arnalich; García, Alejandra García; Gómez-Huelgas, Ricardo; Ramos-Rincón, José-Manuel
Title: In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
  • Cord-id: klojaneu
  • Document date: 2021_8_3
    • ID: klojaneu
    Snippet: BACKGROUND: Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of this study was to evaluate the clinical characteristics and outcome of IS patients hospitalized with COVID-19 compared to non-IS patients. METHODS: We designed a retrospective cohort study. We included all patients hospitalized with laboratory-confirmed COVID-19 from the SEMI-COVID-19 Registry, a large multicentre national cohort in Spain, from March 27(th) u
    Document: BACKGROUND: Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of this study was to evaluate the clinical characteristics and outcome of IS patients hospitalized with COVID-19 compared to non-IS patients. METHODS: We designed a retrospective cohort study. We included all patients hospitalized with laboratory-confirmed COVID-19 from the SEMI-COVID-19 Registry, a large multicentre national cohort in Spain, from March 27(th) until June 19(th), 2020. We used multivariable logistic regression to assess the adjusted odds ratios (aOR) of in-hospital death among IS compared to non-IS patients. RESULTS: Among 13 206 included patients, 2 111 (16.0%) were IS. A total of 166 (1.3%) patients had solid organ (SO) transplant, 1081 (8.2%) had SO neoplasia, 332 (2.5%) had hematologic neoplasia, and 570 (4.3%), 183 (1.4%) and 394 (3.0%) were receiving systemic steroids, biological treatments, and immunosuppressors, respectively. Compared to non-IS patients, the aOR (95% CI) for in-hospital death was 1.60 (1.43–1.79) for all IS patients, 1.39 (1.18–1.63) for patients with SO cancer, 2.31 (1.76–3.03) for patients with haematological cancer and 3.12 (2.23–4.36) for patients with SO transplant. The aOR (95% CI) for death for patients who were receiving systemic steroids, biological treatments and immunosuppressors compared to non-IS patients were 2.16 (1.80–2.61), 1.97 (1.33–2.91) and 2.06 (1.64–2.60), respectively. IS patients had a higher odds than non-IS patients of in-hospital acute respiratory distress syndrome, heart failure, myocarditis, thromboembolic disease and multiorgan failure. CONCLUSIONS: IS patients hospitalized with COVID-19 have a higher odds of in-hospital complications and death compared to non-IS patients.

    Search related documents:
    Co phrase search for related documents
    • acute myocardial infarction and admission prior: 1, 2, 3
    • acute myocardial infarction and admission ray: 1
    • acute myocardial infarction and admission symptom: 1, 2, 3, 4, 5
    • acute myocardial infarction and liver disease: 1, 2, 3, 4, 5, 6
    • acute myocardial infarction and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute myocardial infarction and lung damage: 1, 2, 3, 4
    • acute myocardial infarction and lung transplant: 1
    • acute myocardial infarction and lymphocyte count: 1, 2
    • acute renal failure and admission invasive ventilation: 1
    • acute renal failure and admission prior: 1, 2
    • acute renal failure and liver disease: 1, 2, 3, 4, 5
    • acute renal failure and logistic regression model: 1
    • acute renal failure and long length: 1
    • acute renal failure and low probability: 1
    • acute renal failure and lung cancer: 1
    • acute renal failure and lung damage: 1, 2
    • acute renal failure and lung transplant: 1
    • acute renal failure and lymphocyte count: 1, 2, 3
    • acute respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45